Cocaine regulates TRH-related peptides in rat brain

Neurochemistry International

Volumn 41, Issue 6, 2002, Pages 415-428

  Eugene Pekary, A ^a,b   Senanayake, Shayani ^a   Sattin, Albert ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cocaine; HPLC; Limbic system; Radioimmunoassay; TRH like peptides

Indexed keywords

COCAINE; PROTIRELIN DERIVATIVE; PROTIRELIN[2 LEUCINE]; PROTIRELIN[2 PHENYLALANINE]; PROTIRELIN[2 TYROSINE]; PROTIRELIN[2 VALINE]; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DRUG WITHDRAWAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOREACTIVITY; MALE; MEDULLA OBLONGATA; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN SECRETION; PYRIFORM CORTEX; RADIOIMMUNOASSAY; RAT;

ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; MALE; PEPTIDE FRAGMENTS; PYRROLIDONECARBOXYLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; THYROTROPIN-RELEASING HORMONE; TIME FACTORS;

ANIMALIA;

EID: 0036883470     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00022-0     Document Type: Article

References (75)

1. Abraham, G.E., Grover, P.K., 1971. Covalent linkage of hormonal haptens to protein carriers for use in radioimmunoassay. In: Odell, W.E., Daughaday, W.H. (Eds.), Principles of Competitive Protein-Binding Assays. Lippincott, Philadelphia, pp. 134-139.
2. Bardo M.T. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit. Rev. Neurobiol. 12:1998;37-67.
3. Bennett G.W., Marsden C.A., Fone K.C., Johnson J.V., Heal D.J. TRH-catecholamine interactions in brain and spinal cord. Ann. N.Y. Acad. Sci. 553:1989;106-120.
4. Betts T.A., Smith J., Pidd S., Mackintosh J., Harvey P. The effect of thyrotropin releasing hormone on measures of mood in normal women. Br. J. Clin. Pharmacol. 3:1976;469-473.
5. Callahan A.M., Frye M.A., Marangell L.B., George M.S., Ketter T.A., L'Heurrou T., Post R.M. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics. Biol. Psychiatry. 41:1997;264-272.
6. Chen Y.F., Ramirez V.D. Production and characterization of antisera to synthetic thyrotropin releasing hormone (TRH). J. Histochem. Cytochem. 30:1982;926-931.
7. Dackis C.A., Estroff T.W., Sweeney D.R., Pottash A.L.C., Gold M.S. Specificity of the TRH test for major depression in patients with serious cocaine abuse. Clin. Res. Rep. 142:1985;1097-1099.
8. Delle Donne K.T., Sesack S.R., Pickel V.M. Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Res. 746:1997;239-255.
9. Dworkin S.I., Co C., Smith J.E. Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res. 682:1995;116-126.
10. Fontana D.J., Post R.M., Pert A. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res. 629:1993;31-39.
11. Geis G.S., Wurster R.D. Horseradish peroxidase localization of cardiac vagal preganglionic somata. Brain Res. 182:1980;19-30.
12. Gellman R.L., Aghajanian G.K. Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res. 600:1993;63-73.
13. Gerasimov M.R., Schiffer W.K., Brodie J.D., Lennon I.C., Taylor S.J., Dewey S.L. Gamma-aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine. Eur. J. Pharmacol. 395:2000;129-135.
14. Giannini A.J., Malone D.A., H R., Price W.A. Blunting of the TSH response to TRH in chronic cocaine and phencyclidine abusers. J. Clin. Psychiatry. 48:1987;25-26.
15. Green, C.M., Cockle, S.M., Watson, P.F., Frazer, L.R., 1996. A possible mechanism of action for fertilization promoting peptide, a TRH-related tripeptide that promotes capacitation and fertilizing ability in mammalian spermatozoa. Mol. Reprod. Dev. 45, 244-252.
16. Heidbreder C.A., Oertle T., Feldon J. Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine. Neuroscience. 89:1999;701-715.
17. Heuer H., Ehrchen J., Bauer K., Schafer M.K. Region-specific expression of thyrotropin-releasing hormone-degrading ectoenzyme in the rat central nervous system and pituitary gland. Eur. J. Neurosci. 10:1998;1465-1478.
18. Hinkle, P.M., Pekary, A.E., Senanayaki, S., Sattin, A., 2002. Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides. Brain Res. 935, 59-64.
19. Hokfelt, T.G.M., Castel, M.-N., Morino, P., Zhang, X., Dagerlind, A., 1995. General overview of neuropeptides. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 483-492.
20. Hokfelt T., Tsuruo Y., Ulfhake B., Cullheim S., Arvidsson U., Foster G.A., Schultzberg M., Schalling M., Arborelius L., Freedman J., Post C., Visser T. Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds. Ann. N.Y. Acad. Sci. 553:1989;76-105.
21. Horita A. An update on the CNS actions of TRH and its analogs. Life Sci. 62:1998;1443-1448.
22. Inanami O., Ohno K., Sato A. Responses of regional cerebral blood to intravenous administration of thyrotropin releasing hormone in aged rats. Neurosci. Lett. 143:1992;151-154.
23. Jaworska-Feil L., Budziszewska B., Lason W. Effects of repeated cocaine administration on the thyrotropin-releasing hormone level and receptors in the rat brain. Neuropeptides. 31:1997;253-258.
24. Johansson O., Hokfelt T., Pernow B., Jeffcoate S.L., White N., Steinbusch H.W.M., Verhofstad A.A.J., Emson P.C., Spindel E. Immunohistochemical support of three putative transmitters in one neuron: Coexistence of 5-hydroxytryptamine, Substance P and thyrotropin-releasing hormone-like immunoreactivity in medullar neurons projecting to the spinal cord. Neuroscience. 6:1981;1857-1881.
25. Joyce T., Racine A.D., McCalla S., Wehbeh H. The impact of prenatal exposure to cocaine on newborn costs and length of stay. Health Serv. Res. 30:1995;341-358.
26. Kachidian P., Poulat P., Marlier L., Privat A. Immunohistochemical evidence for the coexistence of substance P, thyrotropin-releasing hormone, GABA, methionin-enkephalin, and leucin-enkephalin in the serotonergic neurons of the caudal raphe nuclei: a dual labeling in the rat. J. Neurosci. Res. 30:1991;521-530.
27. Koenig M.L., Yourick D.L., Meyerhoff J.L. Thyrotropin-releasing hormone (TRH) attenuates glutamate-stimulated increases in calcium in primary neuronal cultures. Brain Res. 730:1996;143-149.
28. Koskinen L.O., Koch M., Svedberg J. Cerebrovascular effects of the TRH analogues pGlu-3-methyl-His-Pro amide and pGlu-Glu-Pro amide: a comparison with TRH. Ups. J. Med. Sci. 105:2000;73-83.
29. Kreider M.S., Wolfinger B.L., Winokur A. Systemic administration of kainic acid produces elevations in TRH in rat central nervous system. Regul. Pept. 28:1990;83-93.
30. Kubek, M.J., 1986. Thyrotropin-releasing hormone: Localization of specific hypothalamic and extrahypothalamic sites of CNS modulation. In: Fredrickson, R.C.A., Hendrie, H., Hingtgen, J.N., Aprison, M.H. (Eds.), Neuroregulation of Autonomic, Endocrine and Immune Systems, 1st Edition. Martinus-Nijhoff, Boston, pp. 265-301.
31. Kubek M.J., Low W.C., Sattin A., Morzorati S.L., Meyerhoff J.L., Larsen S.H. Role of TRH in seizure modulation. Ann. N.Y. Acad. Sci. 553:1989;286-303.
32. Lloyd R.L., Pekary A.E., Sattin A., Amundson T. Antidepressant effects of thyrotropin-releasing hormone analogues using a rodent model of depression. Pharm. Biochem. Behav. 69:2001;15-22.
33. Low W.C., Farber S.D., Hill T.G., Sattin A., Kubek M.J. Evidence for extrinsic and intrinsic sources of thyrotropin-releasing hormone (TRH) in the hippocampal formation as determined by radioimmunoassay and immunocytochemistry. Ann. N.Y. Acad. Sci. 553:1989;574-578.
34. Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 48:1996;113-178.
35. Marangell L.B., George M.S., Callahan A.M., Ketter T.A., Pazzaglia P.J., L'Herrou T.A., Leverich G.S., Post R.M. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Arch. Gen. Psychiatry. 54:1997;214-222.
36. Marsden C.A., Bennett G.W., Fone K.C.F., Johnson J.V. Functional interactions between TRH and 5-hydroxytryptamine (5-HT) and proctolin in rat brain and spinal cord. Ann. N.Y. Acad. Sci. 553:1989;121-134.
37. Mason, G.A., Garabutt, J.C., Prange, A.J., Jr., 1995. Thyrotropin-releasing hormone. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 493-503.
38. McCarty D., Caspi Y., Panas L., Krakow M., Mulligan D.H. Detoxification centers: who's in the revolving door? J. Behav. Health Serv. Res. 27:2000;245-256.
39. O'Cuinn, G. (Ed.), 1995. Metabolism of Brain Peptides. CRC Press, Boca Raton.
40. Pardridge, W.M. (Ed.), Introduction to the Blood-Brain Barrier. Cambridge University Press, Cambridge, 1998.
41. Pekary A.E. Parallel line and relative potency analysis of bioassay and radioimmunoassay data using a desk top computer. Comp. Biol. Med. 9:1979;355-362.
42. Pekary, A.E., Hershman, J.M., 2001. Hormone assays. In: Felig P., Frohman L. (Eds.), Endocrinology and Metabolism, 4th Edition. McGraw-Hill, New York, Chapter 5, pp. 91-107.
43. Pekary A.E., Hershman J.M., Sugawara M., Gieshen K.I., Sogol P.B., Rood A.W., Pardridge W.M., Walfish P.G. Preferential release of triiodothyronine: an intrathyroidal adaptation to reduced serum thyroxine in aging rats. J. Geront. 38:1983;653-659.
44. Pekary A.E., Lukaski H.C., Mena I., Hershman J.M. Processing of TRH precursor peptides in rat brain and pituitary is zinc dependent. Peptides. 12:1991;1025-1032.
45. Pekary A.E., Lukaski H.C., Mena L., Smith S.M., Bhasin S. Testosterone increases TRH biosynthesis in epididymis but not heart of zinc-deficient rats. Peptides. 14:1993;315-324.
46. Pekary A.E., Meyerhoff J.L., Sattin A. Electroconvulsive seizures modulate levels of thyrotropin releasing hormone and related peptides in rat hypothalamus, cingulate and lateral cerebellum, cingulate and lateral cerebellum. Brain Res. 884:2000;174-183.
47. Pekary A.E., Sattin A. Regulation of TRH and TRH-related peptides in rat brain by thyroid and steroid hormones. Peptides. 22:2001;1161-1173.
48. 2 (EEP) in rat brain. Peptides. 20:1999;107-119.
49. Pekary A.E., Sattin A., Lloyd R.L. Electroconvulsive seizures increase levels of Ps4, the TRH-enhancing peptide [Prepro-TRH(160-169)], in rat brain. Neuroendocrinology. 65:1997;377-384.
50. Pierce R.C., Quick E.A., Reeder D.C., Moaargan Z.R., Kalivas P.W. Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 286:1998;1171-1176.
51. Premkumar L.S. Selective potentiation of L-type calcium channel currents by cocaine in cardiac myocytes. Mol. Pharmacol. 56:1999;1138-1142.
52. Reichlin, S., 1986. Control of thyrotropin secretion. In: Ingbar, S.H., Braverman, L.E. (Eds), Werner's The Thyroid, 5th Edition. Lippincott, London, pp. 241-266.
53. Rohsenow D.J., Monti P.M., Martin R.A., Michalec E., Abrams D.B. Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J. Consult. Clin. Psychol. 68:2000;515-520.
54. Rosen, J.B., Cain, C., Weiss, S.R.B., Post, R.M., 1991. Analysis of neuropeptide mRNA expression at different stages of amygdala kindling (Abstr). Soc. Neurosci. Abstr. 17, 510.
55. Sattin A. The role of TRH and related peptides in the mechanism of action of ECT. J. ECT. 15:1999;76-92.
56. Sattin A., Kubek M.J., Low W.C., Staley C.J., Simon J.R. Some regional anatomical relationships of TRH to 5-HT in rat limbic forebrain. Neurochem. Res. 17:1992;469-473.
57. Sattin A., Pekary A.E., Lloyd R.L. TRH gene products are implicated in the antidepressant mechanisms of seizures. Ann. N.Y. Acad. Sci. 739:1994;135-153.
58. Schwarz R.I. Procollagen secretion meets the minimum requirements for the rate-controlling step in the ascorbate induction of procollagen synthesis. J. Biol. Chem. 260:1985;3045-3049.
59. Sesack S.R., Hawrylak V.A., Melchitzky D., Lewis D.A. Dopamine innervation of a subclass of local circuit neurons in monkey pre-frontal cortex: ultrastructural analysis of tyrosine hydroxylase and pravalbumin immunoreactive structures. Cereb. Cortex. 8:1998;614-622.
60. Sevarino K.A., Primus R.J. Cocaine regulation of brain preprothyrotropin-releasing hormone mRNA. J. Neurochem. 60:1993;1151-1154.
61. Shipley, M.T., Mclean, J.H., Zimmer, L.A., Ennis, M., 1996. The olfactory system, In: Swanson, L.W., Bjorklund, A., Hokfelt, T. (Eds.), Handbook of Chemical Neuroanatomy. Integrated Systems of the CNS, Part III. Elsevier, Chapter 3, pp. 469-573.
62. Smiley J.F., Goldman-Rakic P.S. Heterogenous targets of dopamine synapses in monkey pre-frontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. Cereb. Cortex. 3:1993;223-238.
63. Sripada S., Gaytan O., Swann A., Dafny N. The role of MK-801 in sensitization to stimulants. Brain Res. Rev. 35:2001;97-114.
64. Stein E.A., Fuller S.A. Cocaine's time action profile on regional cerebral blood flow in the rat. Brain Res. 626:1993;117-126.
65. Tache, Y., Yang, H., 1994. Role of medullar TRH in the vagal regulation of gastric function. In: Tache, Y., Wingate, D.L., Burks, T.F. (Eds.), Innervation of the Gut: Pathophysiological Implications. CRC Press, Boca Raton, Chapter 5, pp. 67-80.
66. Tsukada H., Harada N., Nishiyama S., Ohba H., Kakiuchi T. Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis. Brain Res. 860:2000;141-148.
67. Visser T.J., Klootwijk W., Docter R., Hennemann G. A new radioimmunoassay of thyrotropin-releasing hormone. FEBS Lett. 83:1977;37-40.
68. Vorel S.R., Liu X., Hayes R.J., Spector J.A., Gardner E.L. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science. 292:2001;1175-1178.
69. Weiss F., Maldonado-Vlaar C.S., Parsons L.H., Kerr T.M., Smith D.L., Ben-Shahar O. Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4321-4326.
70. Wilson I.C., Prange A.J. Jr., Lossen P.T. Psychological and thyroid-stimulating hormone changes after thyrotropin-releasing hormone in normal women: antagonism by pretreatment with thyroid hormones. Psychiatry Res. 2:1980;211-222.
71. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3:2000a;465-471.
72. Xu M., Guo Y., Vvorhees C.V., Zhang J. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res. 852:2000;198-207.
73. Yamada M., Saga Y., Shibusawa N., Hirato J., Murakami M., Iwasaki T., Hashimoto K., Satoh T., Wakabayashi K., Taketo M.M., Mori M. Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10862-10867.
74. Zhang Y., Loonam T.M., Noailles P.A., Angulo J.A. Compaarison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann. N.Y. Acad. Sci. 937:2001;93-120.
75. Zlokovic B.V., Lipovac M.N., Begley D.J., Daavson H., Rakic L.J. Slow penetration of thyrotropin releasing hormone across the blood-brain barrier of in situ perfused guinea-pig brain. J. Neurochem. 51:1988;252-257.